Skip to content

Intraoperative Cell Salvage during caesarean section for placenta accreta

Intraoperative Cell Salvage during caesarean section for placenta accreta

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORN-17013372
Enrollment
Unknown
Registered
2017-11-14
Start date
2015-05-01
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum hemorrhage

Interventions

IOCS group and control group:Intraoperative Blood Salvage

Sponsors

West China Second University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients with pernicious placenta previa undergoing cesarean section in our hospital were selected;Inclusion criteria: Patients with pernicious placenta previa undergoing cesarean section in our hospital were selected

Exclusion criteria

Exclusion criteria: Patients with complications such as: fetal distress, maternal fever, coagulation system disease, preoperative use of anticoagulants, prenatal bleeding, sickle cell anemia, thalassemia, rupture of membranes, amniotic fever, suspected of containing cancer cells should be excluded.If the blood flow out of the blood vessels more than 6h, suspected outflow of blood contaminated by bacteria or disinfectantcell salvage transfusion was forbidded;Exclusion criteria: Patients with complications such as: fetal distress, maternal fever, coagulation system disease, preoperative use of anticoagulants, prenatal bleeding, sickle cell anemia, thalassemia, rupture of membranes, amniotic fever, suspected of containing cancer cells should be excluded.If the blood flow out of the blood vessels more than 6h, suspected outflow of blood contaminated by bacteria or disinfectantcell salvage transfusion was forbidded

Design outcomes

Primary

MeasureTime frame
recovery of blood transfusion;return of blood transfusion;estimated blood loss;allogeneic blood transfusions;blood routine;coagulation routine;maternal adverse events;;recovery of blood transfusion;return of blood transfusion;estimated blood loss;allogeneic blood transfusions;blood routine;coagulation routine;maternal adverse events;

Secondary

MeasureTime frame
duration of surgery;duration of anesthesia;length of postoperative hospital stay;;duration of surgery;duration of anesthesia;length of postoperative hospital stay;

Countries

China

Contacts

Public ContactWei Huang;Wei Huang ;

Department of Anaesthesiology, West China Second University Hospital;Department of Anaesthesiology, West China Second University Hospital

weihuang001@126.com;weihuang001@126.com+86 028-85503753;+86 028-85503753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026